Searching for New Biomarkers to Assess COVID-19 Patients: A Pilot Study

Searching for New Biomarkers to Assess COVID-19 Patients: A Pilot Study

During the initial diagnosis of urgent medical conditions, which include acute infectious diseases, it is important to assess the severity of the patient’s clinical state as quickly as possible. Unlike individual biochemical or physiological indicators, derived indices make it possible to better cha...

Full description

Bibliographic Details
Main Authors:	Nikolay V. Goncharov, Piotr P. Avdonin, Natalia G. Voitenko, Polina A. Voronina, Polina I. Popova, Artemy V. Novozhilov, Maria S. Blinova, Victoria S. Popkova, Daria A. Belinskaia, Pavel V. Avdonin
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Metabolites
Subjects:	von Willebrand factor COVID-19 endothelial cells diagnostics biomarker albumin
Online Access:	https://www.mdpi.com/2218-1989/13/12/1194

Similar Items

VAS2870 Inhibits Histamine-Induced Calcium Signaling and vWF Secretion in Human Umbilical Vein Endothelial Cells
by: Pavel V. Avdonin, et al.
Published: (2019-02-01)

A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS
by: Khadizha M. Emirova, et al.
Published: (2023-11-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

The von Willebrand factor as a marker of partially controlled asthma severity in children
by: N.I. Makieieva, et al.
Published: (2023-09-01)

Albumin Is a Component of the Esterase Status of Human Blood Plasma
by: Daria A. Belinskaia, et al.
Published: (2023-06-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Effect of Supplemental Oxygen on von Willebrand Factor Activity and Ristocetin Cofactor Activity in Patients at Risk for Cardiovascular Complications Undergoing Moderate-to High-Risk Major Noncardiac Surgery—A Secondary Analysis of a Randomized Trial
by: Katharina Horvath, et al.
Published: (2023-02-01)

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease
by: Muhammad Asif Naveed, et al.
Published: (2022-05-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

Diagnosis of von Willebrand disease during the management of deep neck abscess: A case report
by: Akihisa Tanaka, et al.
Published: (2022-12-01)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Vascular factor dynamics in therapy for microangiopathy with underlying type 1 diabetes mellitus
by: E. S. Krutikov, et al.
Published: (2020-12-01)

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2018-05-01)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
by: Marcela Montilla, et al.
Published: (2022-11-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
by: Marie‐Daniéla Dubois, et al.
Published: (2022-05-01)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
by: Alessandra Casonato, et al.
Published: (2021-08-01)

Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties
by: Daria A. Belinskaia, et al.
Published: (2021-09-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
by: Jessica Garcia, et al.
Published: (2020-01-01)

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01)

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
by: Martin Büchsel, et al.
Published: (2023-01-01)

Rictor maintains endothelial integrity under shear stress
by: Hui Li, et al.
Published: (2022-11-01)

Von Willebrand factor and gastric cancer – is there an association? – A pilot study from South India
by: Karthikeyan S, et al.
Published: (2024-03-01)

Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection
by: Quan Zhang, et al.
Published: (2023-11-01)

Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients
by: Roberta Gualtierotti, et al.
Published: (2023-05-01)

Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis
by: I. A. Koltsov, et al.
Published: (2021-09-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

بررسی درصد فراوانی بیماری von Willebrand در زنان با خونریزی شدید قاعدگی
by: Fariborz Mokarian, et al.
Published: (2018-10-01)

Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis
by: Swiss Medical Weekly
Published: (2002-04-01)

Clinicopathological Profile of the von Willebrand Disease in a Tertiary Care Centre in Varanasi
by: Pawan K. Pandey, et al.
Published: (2022-03-01)

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
by: T V Antonova, et al.
Published: (2013-12-01)

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
by: Pamela A. Christopherson, et al.
Published: (2022-10-01)